2017 - American Pharmacists Association Voters Guide 2017.pdf2017 VOTER’S GUIDE ... Rebecca W....

2017VOTER’S GUIDEAPhA Board of Trustees ......................................................................2–8

APhA Honorary President ....................................................................... 9

APhA Academy of Pharmaceutical Research

and Science (APhA-APRS) ...............................................................10–16

APhA Academy of Pharmacy Practice

and Management (APhA-APPM) .................................................... 17–21

ALL BALLOTS MUST BE RECEIVED NO LATER THAN 12:00 NOON, EDT, MONDAY, MAY 22, 2017.

SAVE TIME . . . CAST YOUR VOTE ONLINE

American Pharmacists Association

2215 Constitution Avenue, NW

Washington, DC 20037-2985

1

All ballots must be received by 12 Noon, EDT, Monday, May 22, 2017

“Ask the Candidate!”Find out where the candidates stand on the issues that matter most to you and your area of practice. Contact the candidates at the email addresses provided to learn more about their campaign goals and professional interests.

Who is Entitled to Vote?Each ballot is customized according to the information found in the voting member’s online membership profile. APhA members and select Student Pharmacist members are entitled to vote for the candidates for the APhA Board of Trustees and for the leadership of their designated primary Academy and Section (if applicable). Technician members are only entitled to vote for the leadership of their designated primary Academy and Section (if applicable).

How to Vote

Voting OnlineEach eligible member will receive an individualized email from Election Services Co. (ESC) with candidate and ballot information. Online voting is highly encouraged. If you prefer to receive a paper ballot at your home address, please contact ESC at [email protected], as paper ballots will only be sent upon request.

• Go to https://www.esc-vote.com/apha2017 to access the log-in page of the official 2017 APhA election.

• Log-in using your Election Validation Number (EVN) and your Member Number (MN) located in your email.

• Follow the online voting instructions.

• Your vote must be received by 12 Noon, EDT, Monday, May 22, 2017.

Voting by Mailing Paper Ballot

• Please contact ESC at [email protected] to request a paper ballot.

• Mark your selection by placing an “X” in the box to the left of the candidate’s name.

• Detach the bottom panel. Do not mail with ballot.

• Return ballot in the enclosed envelope.

• Fill in your return mailing address on the envelope. Affix appropriate postage (airmail, if foreign).

• Mail your ballot to Election Services Co., P.O. Box 9020, Ronkonkoma, NY 11779.

Please allow one week for delivery.

• Ballot must be received by 12 Noon, EDT, Monday, May 22, 2017.

ConfidentialityBallot confidentiality is provided through processing and tabulating by an independent firm.

Remember, your vote counts! Make your voice heard.

BO

AR

D O

F T

RU

ST

EE

S

AMERICAN PHARMACISTS ASSOCIATION

Board of Trustees ElectionSpring 2017

Candidates for President-elect and Trustee were asked to respond to the following question. The candidates’ responses are italicized.

(See pages 3–8.)

Recognizing that a strong association supports the advancement of the profession, what areas would you focus the organization’s limited resources on to achieve

APhA’s current mission and vision and to advance the profession?

APhA MissionThe American Pharmacists Association empowers its members

to improve medication use and advance patient care.

2

BO

AR

D O

F T

RU

ST

EE

S

3

Rebecca W. Chater, RPh, MPH, FAPhA is a career-long pioneer in innovative community-based clinical pharmacy practice. She earned both her B.S. in Pharmacy and Masters in Public Health from UNC-Chapel Hill. Chater is Executive Healthcare Strategist for Ateb, an Omnicell company and leading healthcare technology provider specializing in community pharmacy integration into the broader healthcare system. Throughout her career, Chater has

championed the pharmacist as a medication expert, integral to the healthcare team in solving systemic problems around medication use. Chater’s career in pharmacy spans community practice, medi-cal practice, academia, long-term care, and specialty pharmacy. In the late ‘90s, she led regional Kerr Drug to national prominence by spearheading Kerr’s foray into community pharmacy-based clinical services utilizing an appointment-based model. Chater served as a two-term elected Member and Past President of the North Carolina Board of Pharmacy, during which time, she authored initial draft Immunization Rule language opening the door to vaccination authority for North Carolina’s pharmacists. Chater is a past Trustee and Fellow of APhA and has received numerous state and national awards for professional leadership, mentorship, and innovation including the prestigious APhA Gloria Niemeyer Franke Leadership Mentor Award, the APhA Foundation Pinnacle Award, the APhA-APPM Administrative Practice Excellence Award, the North Carolina Pharmacist-Preceptor of the Year, the North Carolina Association of Pharmacists’ Innovative Practice Award, and the UNC Eshelman School of Pharmacy Distinguished Service Award. Chater has nearly 200 publications and invited presentations to her credit, including co-authoring the Institute of Medicine Quality Chasm series publication, Preventing Medication Errors.

Email: [email protected]

Recognizing that a strong association supports the advancement of the profession, what areas would you focus the organization’s limited resources on to achieve APhA’s current mission and vision and to advance the profession?

While many aspects of the emerging healthcare landscape are unknown, it’s clear that our future healthcare economy will be value-based, requiring providers to care proactively for entire patient popu-lations and be compensated based upon outcomes achieved rather than the services they deliver. APhA has long been a clear catalyst in advancing societal recognition of the value of the pharmacist. Advocacy, collaboration, and education are three primary areas that warrant ongoing allocation of resources to achieve APhA’s mission and vision.

1. Advocacy. APhA has successfully led advocacy efforts to advance pharmacists’ provider status at the grassroots level and on Capitol Hill. Achievement of provider status will dramatically improve access to care in areas where Americans need it most, and is essen-tial to improving quality of care and reducing healthcare costs.

2. Collaboration. Synergy through collaboration with national and state professional associations and other healthcare stakeholders is another key area where APhA’s resources are needed. It is through meaningful collaboration and alignment of our common goals—better quality, better care, and lower costs—that pharmacists will be optimally positioned to improve medication use and patient care as integral members of the healthcare team.

3. Education. As we face an imminent shortage of primary care pro-viders, revitalized support for postgraduate residency education of pharmacists will be required. Likewise, innovative approaches to equip pharmacists with tools to meet the demands of population health management and successfully navigate the future value-based healthcare economy should also be a priority of APhA.

Allocation of APhA’s resources to advocacy, collaboration, and educa-tion will support pharmacists’ transition to value-based, outcomes-focused healthcare and position our members as leaders, not just within the pharmacy profession, but for the future of our nation’s health care.

APhA President-elect (2018–2019)

BO

AR

D O

F T

RU

ST

EE

S

4

APhA President-elect (2018–2019)

Brad Tice, PharmD, MBA, FAPhA (twitter: @bradtice, #Tice2018) is the Director/Product Leader of Medication Therapy Management for Cardinal Health. Dr. Tice received his Bachelor of Science degree in 1994 and PharmD in 1996 from the University of Kansas. He also earned an MBA from the Vanderbilt University Owen School of Management in 2012. His career has spanned the pharmacy spectrum working with independent,

chain and hospital pharmacies through Cardinal Health, entrepre-neurial start-ups, independent and chain community pharmacy practice, academia at Drake University, and managed care. His entire career has focused on elevating the profession by empowering pharmacists to improve patient care and ensuring pharmacists are recognized and compensated for the services they provide. He cur-rently serves APhA as Trustee-at-Large and has also served as Speaker of the APhA House of Delegates. He has served on the executive committee of the Academy of Pharmacy Practice and Management (APPM), as an APhA-ASP national student Member-at-Large, and in several other elected and volunteer positions. He has also served the profession in numerous other capacities including the Pharmacy Quality Alliance, serving as initial consultant and workgroup chair, on technical expert panels regarding quality measure development (NCQA, CMS), committees with AACP and AMCP, and Speaker of the House and Board of Trustees of the Iowa Pharmacy Association. His professional recognitions include: Cardinal Health’s 2015 Product Leader of the Year, APhA’s 2010 Distinguished Achievement Award in Clinical/Pharmacotherapeutic Practice, APhA—Fellow (2008), Prescott Leadership Award (2005), and the Iowa Pharmacy Association’s Young Pharmacist of the Year (2002).



Through strong leadership and a vision where pharmacists are viewed as essential to care, APhA must use its resources to:

1. Advance Provider Status—I am proud to have been a member of the APhA Board of Trustees who voted to initiate and support a massive effort toward establishing provider status for pharmacists. With over $3 million committed to make this happen so far—more than any other association—we have had great success in mobiliz-ing and unifying the profession and have seen great support in Congress. We must see this effort through to reality! We must also work in parallel to ensure the opportunities and infrastructure are created for pharmacists to be appropriately compensated for their contributions to patient care.

2. Expand Compensation for Pharmacist Patient Care Services—Pharmacists must be paid for the value they bring to the healthcare system and must have more opportunities to be compensated for their contributions. Payment models are rapidly changing from fee-for-service to value-based payments. We must prepare for this change and establish pharmacists’ capabilities in this new system while simultaneously helping patients and payers realize the ben-efits of involving pharmacists in healthcare decision-making.

3. Increase Value for Members—An association is only as strong as the size and engagement of its membership. We must strengthen the value of membership today and attract new members to build upon our accomplishments. This requires having a pulse on the profession and listening to pharmacists to strategically address the pain points of today while developing diverse opportunities for tomorrow. To do this we must leverage the talents of current members to a greater extent and use their valuable ideas and experiences to attract new members and further advance our profession.

I would be honored to represent you. I humbly ask for your vote. Thank you.

BO

AR

D O

F T

RU

ST

EE

S

5

APhA Board of Trustees (2018–2021), Pair I

Gregory A. Fox, RPh is a current APhA Trustee and Pharmacy Merchandiser for The Kroger Co.’s Central Market-ing Area, encompassing Indiana, Illinois, and parts of Missouri, Michigan, and Ohio. Fox’s experi-ence includes community, man-aged care, long term care, and consultant pharmacy. He served on numerous health insurance plan boards as a board member or P&T committee member. He received his

pharmacy degree from the University of Cincinnati and is a gradu-ate of the University of Mississippi APhA Community Pharmacy Business Management Program. A very active APhA member, Fox is a Trustee and a contributing member of the Finance Committee, Government Affairs Committee, Political Action Committee, and the Strategic Directions Committee. He is a mem-ber of the APhA APPM section and is a House Delegate and a con-tributing author. Included on his resume is the President of the Ohio Pharmacists Association when legislation passed allowing pharmacists to immunize and provide collaborative services. He initiated and testified for similar laws in Indiana. Fox serves on the Indiana Board of Pharmacy Technology Committee, Indiana Pharmacists Alliance, Ohio Pharmacists Association, Indiana and Illinois Retail Committees, and the Medication Safety Partnership of Indiana. Fox is responsible for the development of the Kroger/ Purdue Community Pharmacy Residency. He is an Adjunct Professor of Pharmacy Practice for several Colleges of Pharmacy and sits on three Pharmacy Dean’s Councils. Fox was awarded the BCPA Pharmacist of the Year, Ohio’s Young Pharmacist of the Year and Kroger Chairman’s Award. Purdue recognized Fox with the 2010 “Friend of Pharmacy Award” for dedication to the profession and the College.



The advancement of the profession’s direction for APhA is determined by its membership and the House of Delegates. Having a keen sense of what the House has directed along with the work of the Strategic Directions Committee allows the organization to create a plan for the future. APhA’s strongest asset is the membership. Leveraging members throughout the United States will drive the change. The Pharmacists Provide Care campaign is evidence of the strength of pharmacists as numerous members have become advocates and written letters to Congress. Keeping our message clear to the membership will drive the advancement of the profession.

The annual meeting remains a large and valuable way to commu-nicate a message and has the most involved pharmacists attending. We need to ensure these attendees are armed with the current mis-sion and vision. Additionally APhA’s publications and use of technol-ogy via social media and the web are excellent. It’s a strength that we can continue to utilize for communication and promotion.

APhA is well respected on The Hill. Utilizing our political strength via our membership and affiliated state associations is a valuable resource in advancing the profession. The pharmacy profession is in the enviable position to have patients as an additional voice to pro-mote our future along with pharmacists. We can utilize our patient relationships via our strong pharmacist membership to aid our cause by monitoring our intervention results that demonstrate our progress in delivering better patient outcomes.

Pharmacy education is the root of how we will proceed as a pro-fession. Our college education is very strong today to develop a tre-mendous pharmacist to practice in almost any environment. APhA’s Continuing Education is bar none, the best in the business. I believe APhA has to work to leverage our education strength in creating the future of pharmacy practice.

Magaly Rodriguez de Bittner, PharmD, FAPhA, is a Professor, Associate Dean for Clinical Services and Practice Transformation and Executive Director of the Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy. Currently, she is a Fellow in Population Health at the University of Maryland Health System. Her role as a pharmacy faculty has led to the development of many nationally rec-ognized innovative programs, includ-

ing the Giant Diabetes Education Program and the Maryland P3 Program- a pharmacist-directed MTM and chronic disease manage-ment program prior site of Ten City Challenge- in partnership with the Maryland Pharmacists Association, government and business organi-zations. Past director of the Community Pharmacy Residency Program and current preceptor. She regularly speaks at national and interna-tional forums on development and implementation of pharmacist-directed services. Her work includes collaborations with the CDC and other government agencies. She is past President of the Maryland Pharmacists Association and APhA Foundation Board, APhA Fellow and served on APhA committees and taskforces, including the Forum of the Americas. Recipient of the 2015 APhA Foundation Pinnacle Award for Individual Career Achievement, 2014 Maryland Innovator of the Year, 2013 University of Maryland Entrepreneur of the Year, the 2013 American Pharmacists Association Daniel B. Smith award, the 2010 Group Pinnacle Award; 2007 APhA Community Pharmacy Residency Excellence in Precepting Award and Bowl of Hygeia 2005. She has dedicated her career to advance pharmacy practice and the development of innovative and sustainable patient care programs to maximize the impact of pharmacists in patient care.



I commend APhA on its efforts to secure provider status for pharmacists—a very important issue for the profession—but I also believe that we must start evaluating our members’ needs related to incorporating and integrating pharmacists’ services into value-based payment models and accountable care organizations. In addition, we should advocate for legislative and regulatory changes that recognize the essential role of pharmacists on the core care team within these models.

While fee for service will remain a key issue in the next few years, we need to pay attention to the pharmacist’s emerging role in these new value-based models, which most likely will continue to exist even in the presence of anticipated changes to the Affordable Care Act. During my time as a Population Health Fellow, I have come to recog-nize that is imperative to demonstrate the role of pharmacy in these settings and create resources and tools for pharmacists to integrate their services within these models of care.

While resources are limited, the creation of collaborative efforts with health systems, government agencies, pharmacy organizations, and academic institutions such as schools of pharmacy can advance this important issue without creating significant burden on the asso-ciation. With the current uncertainty about the future of health care, pharmacy associations and institutions should make every effort to collaborate, maximize resources and whenever possible, speak with a unified voice.

Many health care institutions and schools of pharmacy have started to develop, implement, and evaluate these innovative care delivery models. APhA should serve as an integral partner and collaborator in testing, disseminating, and advocating for these innovative pharmacy services to its pharmacists and student members and the profession at large.

BO

AR

D O

F T

RU

ST

EE

S

6

APhA Board of Trustees (2018–2021), Pair I

BO

AR

D O

F T

RU

ST

EE

S

7

Sean Jeffery, Pharm.D., CGP, FASCP, AGSF, is Director of Clinical Pharmacy Services at Integrated Care Partners, an accountable care organization responsible for Hartford Healthcare Group’s value-based prac-tice transformation. His career has focused on implementing innovative patient care services for seniors that promote the value of pharmacists in care coordination. Currently, he is responsible for pharmacy network development and strategy, pop-

ulation health management, and support of an integrated care- management team. He is also a Clinical Professor at the University of Connecticut School of Pharmacy. He was previously a consultant pharmacist at the VA Connecticut Healthcare System where he served as a PGY2 Geriatrics Residency Program Director. Jeffery currently serves on the 2016–2017 APhA Policy Committee and chairs the Polypharmacy Special Interest Group for the American Geriatrics Society. He also served as President and Chairman of the Board of Directors for the American Society of Consultant Pharmacists from 2012–2014 and Chair of the American Association of Colleges of Pharmacy Geriatrics SIG in 2007–2008. He cofounded the Coalition for Senior Medication Safety in New Haven, CT to raise awareness among seniors about medication safety. He was recognized as a Fellow of the American Geriatrics Society (2016), an Ohio State University Distinguished Alumni (2013) and received the Elan Biopharmaceuticals Innovative Pharmacy Practice Award (2006). He earned his bachelor of science from the University of Connecticut and PharmD from the Ohio State University.



To borrow a line from Hamilton, “When you got skin in the game, you stay in the game; But you don’t get a win unless you play in the game.” Every pharmacist has skin in the value-based healthcare game! Our profession however needs all pharmacists playing in the game as well. Look around, how lucky we are to be practicing at this pivotal moment in time! The opportunities being created through value-based healthcare reforms will transform all aspects of pharmacy practice. As part of the senior leadership team of an accountable care organization, I’m fortunate to be in a position to expand pharmacist roles. Every day our organization grapples with how to improve the quality of care we provide, while reducing our total cost of care. We are not unique in this struggle, and will never be successful if pharmacists are not “playing in the game” and recognized as healthcare providers. Trying to manage total cost of care and improve quality without incor-porating pharmacists is a prescription for failure.

Throughout my career I have served in a variety of leadership positions in professional organizations and the private sector. I believe more pharmacists would be “playing in the game” if they better understand the stakes (skin in the game) and were encour-aged by their employers. APhA needs to prepare pharmacists and employers with transformative practice tools and practical education to deliver the skills needed to succeed. Let’s focus resources on help-ing members transform their practices to align with the triple aim. Understanding CMS’s Quality Payment Program for physicians will help members realize their true potential in a value-based healthcare economy. APhA also needs to help members address the many work-life challenges they face in today’s metric-driven positions. The pros-pects for pharmacists to improve care, reduce costs and work across care settings have never been greater.

APhA Board of Trustees (2018–2021), Pair II

BO

AR

D O

F T

RU

ST

EE

S

8

APhA Board of Trustees (2018–2021), Pair II

Theresa Tolle, BPharm, FAPhA, is owner of Bay Street Pharmacy in Sebastian, Florida for the past 17 years. Prior to owning an indepen-dent pharmacy, she had practice experience in chain, long term care (consultant) pharmacy and hospital. Her pharmacy focuses on patient services such as counseling, MTM, compounding, immunizations and pharmacogenomics testing. Her professional activities have spanned local, state and national pharmacy

associations including serving as President of Florida Pharmacy Association in 2003, Treasurer of the Florida Pharmacy Political Committee since 2009, APhA-APPM Community & Ambulatory Chair 1995–1996, PAC Region 2 Board of Governors 2009–2012 and Speaker–Elect/Speaker of the House 2014–2017. As Speaker, she currently serves as a Trustee for APhA. Other APhA service includes appointments to various House of Delegates committees includ-ing Policy Committee Chair in 2010–2011, AMCP Model Audit Guidelines Task Group, 2010–2011 and CPPA Oversight Committee 2012–2013. Additional professional involvement includes mem-bership and committee work with NCPA, Cardinal Health National Advisory Board, Health First Health Plans P&T Committee and Creative Pharmacist Advisory Board. Activities outside the profession include Sebastian Chamber of Commerce Immediate Past Board Chair & LGA Chair, American Cancer Society Treasure Coast Council, and Sebastian River Medical Center Trustee. Tolle graduated from University of Florida in 1988. She has won several professional awards including the Palm Beach Atlantic University Community Pharmacy Preceptor of the Year in 2015, Bowl of Hygeia in 2012, APhA Fellow in 2011, APhA Good Government Pharmacist of the Year in 2004 and Cardinal Health’s Ken Wurster Community Leadership Award in 2011.



APhA’s vision can be summarized to state that pharmacists are the health care provider who ensures optimal medication use to improve quality of life. I believe that APhA has focused its resources on this vision through its priorities of ensuring pharmacists become providers of record within Medicare and also helping develop practice resources for pharmacists to succeed in the evolving value-based health care models. Our association, through its leadership and members, has been visionary in looking to provide solutions and opportunities to position pharmacists as the medication experts. I feel that APhA has its priorities correct and should continue to provide quality education programs, advocate on behalf of its members and patients and collaborate with related organizations to ensure pharmacists role within the health care team.

9

APhA Honorary President (2018–2019)

HO

NO

RA

RY

PR

ES

IDE

NT

Stanley M. Shaw, PhD, FAPhA, FASHP, FFIP

Stanley M. Shaw, PhD, FAPhA, FASHP, FFIP is a Professor Emeritus, Nuclear Pharmacy at Purdue University College of

Pharmacy. He received a B.S. in Pharmacy and M.S. in Pharmaceutical Science from South Dakota State University and

a Ph.D. in Bionucleonics from Purdue. As a faculty member in Bionucleonics he conducted radioactive tracer research in

the 1960’s. In the early 1970’s his love for pharmacy propelled him to focus on nuclear pharmacy and become one of

the leaders in the development of education, professional matters and recognition as a specialty practice in pharmacy.

He was a co-organizer of the first nuclear pharmacy session held at the APhA Annual Meeting in 1974. He joined with

others to petition for the formation of the Section on Nuclear Pharmacy and for recognition of nuclear pharmacy as the

first specialty practice by the BPS. Following recognition he was appointed as a founding member of the BPS Specialty

Council on Nuclear Pharmacy. Dr. Shaw was appointed as Vice Chairman Pro Tem of the new Section and elected

as chairman twice. He served on countless nuclear pharmacy committees, presented orally at meetings, served as

Section Historian as well as on the APhA House of Delegates. His involvement in APhA spans over 40 years. Dr. Shaw

was recognized by APhA as a Fellow, as a recipient of the Distinguished Achievement Award in Nuclear Pharmacy

and the Daniel B. Smith Practice Excellence Award. He was recognized by South Dakota State University as a

distinguished alumnus in education and by the AACP as an educator. He credits his career to the Lord, the nuclear

pharmacy team and his super pharmacist wife, his rock of support.

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

10


Academy of Pharmaceutical Research and Science (APhA-APRS) Election

Spring 2017

Candidates for APhA–APRS office were asked to respond to the following question. The candidates’ responses are italicized.

(See pages 11–16.)

What are the top three priorities of the Academy and what experiences and expertise can you contribute to meeting these priorities?

APhA-APRS Mission StatementThe APhA Academy of Pharmaceutical Research and Science stimulates the

discovery, dissemination and application of research to improve patient health.

Who is Entitled to Vote?All members of the American Pharmacists Association who have designated a Primary Academy and Section (if applicable) are entitled to vote for the leadership of that Academy and Section.

Members who have not designated a Primary Academy and/or Section (if applicable) are encouraged to follow the steps below to fully participate in the 2017 APhA Election:

1. Log-in to your member profile at www.pharmacist.com.2. Select “My Account” in the top right corner.3. Select “Academy, Sections, and SIGs” in the menu bar on the left side.4. Click on “Edit” in the top right corner to be able to choose your Primary Academy and/or Section

(if applicable).5. Designate your Primary Academy and Section (if applicable).6. Designate your Secondary Academy, Section, and/or Special Interest Group preferences (if desired). 7. When your selection(s) are complete, click on the purple “Save” button in the top right corner or the

bottom left corner.

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

11

Jennifer T. Lamberts, PhD, is an Assistant Professor of Pharmacology at Ferris State University College of Pharmacy. She earned a Bachelor of Arts degree in Chemistry from Kalamazoo College and a PhD in Pharmacology from University of Michigan. She completed her postdoctoral training in neurodegen-erative science at Van Andel Research Institute in Grand Rapids, Michigan. Dr. Lamberts then joined the faculty at Ferris State University in 2014.

Dr. Lamberts’ research interests include defining the cellular mechanisms responsible for Parkinson’s disease pathogenesis, including (but not limited to) inflammation, protein aggregation, transport defects, and energy dysregulation. She greatly enjoys working with students in the lab, and she is proud to serve as the advisor to a recipient of a 2016 AFPE Gateway Research Scholarship.

Dr. Lamberts is active in several professional societies, including American Society for Pharmacology and Experimental Therapeutics and National Postdoctoral Association. In particular, she recently served as the Co-Chair of the Meetings Committee for the National Postdoctoral Association where she was responsible for overseeing the planning of the organization’s annual meeting.

Dr. Lamberts also enjoys facilitating student learning in the classroom. She is currently Course Director of Pathophysiology 1 and 2, and teaches several topics in Drug Action.


My priorities as APhA-APRS Basic Sciences Chair-elect would be as follows:

1. To enhance collaboration between Pharmacy Practice and Pharmaceutical Sciences faculty—Within the College of Pharmacy at Ferris State University, I recently organized a “Research Roundtable” seminar series in which faculty present ongoing and proposed research to other faculty, staff, and administrators. The goal of this program is to build connections between clinical and basic science faculty. I organized these sessions because I believe that strengthening connections between the bench and the clinic is the best way to develop novel and exciting research programs. Thus, my experience in cross-disciplinary collaboration will help me meet this priority.

2. To contribute exciting, relevant scientific content to the APhA annual meeting—My role as Co-Chair of the Meetings Committee for the National Postdoctoral Association has given me significant expertise in the art of planning a national meeting. From assessing the needs of members, meeting attendees, and stakeholders, to soliciting and reviewing propos-als, to planning meeting logistics, I have been involved in all aspects of preparing and running the annual meeting of a national organization.

3. To increase participation of pharmaceutical scientists in APhA-APRS— I believe that by increasing the visibility of the academy through net-working and social media, we can recruit more basic scientists to join and contribute to the mission. I would use my experience in promoting other organizations, such as the National Postdoctoral Association and Van Andel Institute, to let pharmaceutical scientists nationwide know what APhA-APRS has to offer basic scientists, and encourage them to join.

Anna Ratka, PhD, PharmD, RPh, CPE, is a profes-sor and interim associate dean of academic affairs at College of Pharmacy, Chicago State University. Dr. Ratka earned M.S. in pharmacy and Ph.D. in pharma-cology from Poznan University of Medical Sciences, Poland, and Pharm.D. from Idaho State University. She completed two post-doctoral fellowships. She was a pharmacy faculty at Idaho State University for 11 years. At University of North Texas Health Science Center, she was founding Director of Clinical

Research at Institute for Aging and Alzheimer’s Disease Research. Dr. Ratka was founding chair of the Department of Pharmaceutical Sciences at Texas A&M College of Pharmacy and contributed to its accreditation. At Chicago State University, she chaired the Department of Pharmaceutical Sciences and now holds position of interim associate dean of academic affairs. Dr. Ratka is a graduate from the American Association of Colleges of Pharmacy Academic Leadership Fellows Program. She serves as evaluator for Accreditation Council of Pharmacy Education.

Dr. Ratka has taught pharmacology, basic pharmacokinetics, pain phar-macotherapy, and sterile compounding. She is Certified Pain Educator. Her research is in neuropharmacology, neuroscience, and pain. Dr. Ratka authored over 100 publications and presentations. She has served in leader-ship positions in professional organizations. As a leader, Dr. Ratka is produc-tive, focused on tasks and results, good problem solver, and effective in developing partnerships and collaborations. As pharmacist, she has practiced in community and hospital pharmacy settings. She is engaged in volunteer service to underserved communities.


Top priorities:

1. Develop new programs involving student pharmacists and residents by developing collaborative activities with students, residents, and their leaders.

2. Recruit new members and develop programmatic activities that welcome faculty participation and support mentoring and development of pharmacy faculty.

3. Develop a strategic plan with goals and objectives to enhance Academy’s contributions to American Pharmacists Association.

Basic Sciences Section Chair-elect (2018–2019)

APhA-APRS Executive Council

12

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

What is the APhA-APRS Section on Basic Pharmaceutical Sciences?

This Section serves academic and industrial scientists with wide-ranging basic science research programs. The research interests of Section members span chemical structure/biological

activity and chemical structure/physicochemical property relationships, concepts in pharmaceutical technology and drug delivery, and the basic physical chemistry upon which these are based.

2017 VOTE

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

13

APhA-APRS Executive Council

Clinical Sciences Section Chair-elect (2018–2019)

Roger D. Lander, PharmD, FASHP, FCCP, BCACP, currently serves as Professor of Pharmacy Practice at the McWhorter School of Pharmacy, Samford University, in Birmingham, Alabama, USA. He received his B.S.in Pharmacy and PharmD from the University of Missouri-Kansas City and completed a clinical pharmacy residency at Truman Medical Center. He then served four years as a faculty mem-ber at UMKC’s Schools of Medicine and Pharmacy. Moving to Samford in 1986, he has developed prac-

tices in adult medicine, nutrition, ambulatory care, and pharmacokinetics. He served as Vice-Chair, then Chair and Assistant Dean for Practice Programs for 10 years. In 2003, Professor Lander developed ambulatory clinical phar-macy services at the Jefferson County Health Department, where he started and directed a PGY1 residency training program. In 1994, Professor Lander helped develop a clerkship for Samford students at Guy’s and St. Thomas’ Hospitals in London, England and assisted the pharmacy department there in the development of their ambulatory anticoagulation services. Dr. Lander helped establish Samford’s faculty/student exchange program with Meijo University in Nagoya, Japan and has traveled widely throughout Japan and Asia for information exchange and to assist colleges and hospitals in their clinical teaching and practice. He has also helped develop study opportuni-ties at Samford for pharmacists from England, Japan, Korea, China, Malaysia, Indonesia, and most recently Vietnam. Dr. Lander is also one of the founders of the Asian Conference on Clinical Pharmacy, which originated with 37 Asian delegates attending a meeting at Samford University in 1997. This meet-ing, now held annually in various Asian countries, typically attracts some 800–1200 participants from more than fifteen countries.


I believe the three top priorities of the Academy should be discovery, advancing practice, and mentorship. Discovery should include scientific elucidation of new therapeutic agents, investigation of those agents in disease, and improving care processes in the practice of pharmacy and the advancement of the roles of the pharmacist in the evolving health care system. Advancing practice with these discoveries must include communication and dissemination of results to practitioners and scientists alike, and include the promotion and advocacy of pharmacists’ services to a broad audience. Mentorship is very important in that guidance/support of younger pharmacists and students is crucial to growth of our profession. My experience and skills enable me to serve our section to grow in all three of these areas. I have conducted basic pharmacokinetic, clinical effectiveness and practice outcomes research during my career, giving me a well-developed perspective on the relationship and inter-connectivity of these three priorities. Through my teaching of students, residents, and practicing pharmacists here in the US, as well as internationally throughout Europe and Asia, I am experienced and committed to the integration of evidence-based science into building better prepared pharmacists for today and into the future. Through my ongoing practice activities, I am able to be a mentor to others as well as continue to learn new solutions to the problems presented by my patients. I am willing to commit time and effort to the advancement of the Academy.

2017 VOTE

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

14

2017 VOTE

What is the APhA-APRS Section on Clinical Sciences?

This Section provides unique multidisciplinary interaction between clinical scientists and practitioners committed to expanding knowledge of the safe and effective use of

drug products. A particular interest of members is how the application of pharmaceutical sciences in organized healthcare settings and controlled research environments relates

to evaluation and development of drugs and drug delivery systems.

What is the APhA-APRS Section on Economic, Social and Administrative Sciences (ESAS)?

This Section is home to those interested in health services research, policy and administration with application to pharmaceutical treatments and pharmaceutical care. Membership is multidisciplinary, including the fields of public health, epidemiology, economics, health

services research, biostatistics, medical sociology, law, healthcare administration and management, operations research, pharmaceutical marketing, marketing research, technology assessment and applications, and public and private reimbursement programs. Membership

affords the opportunity for interaction among scientists, educators and practitioners, government managers, and other healthcare system representatives.

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

15

Spencer E. Harpe, PharmD, PhD, MPH, is Associate Professor of Pharmacy Administration at Midwestern University Chicago College of Pharmacy where he teaches courses in pharmacy manage-ment, health care quality, epidemiology, and statis-tics. He holds a BS in Pharmaceutical Sciences and a PharmD from the University of Mississippi. Harpe earned his PhD in Pharmaceutical Administration with a focus on health outcomes research from the Ohio State University, as well as an MS in

Pharmaceutical Administration and an MPH with a concentration in biosta-tistics. His research interests include pharmacoepidemiology, outcomes research, and health care quality. Harpe frequently collaborates with col-leagues in various practice settings to evaluate the outcomes and impacts of pharmacy services. He also has an interest in educational research, especially related to methods for teaching statistics and research and evaluation meth-ods. His research has resulted in numerous peer-reviewed publications and presentations at national and international meetings. Harpe has served on committees for several professional organizations. From 2014 to 2016, he served on the APhA-APRS ESAS Contributed Papers Review Committee and was chair of that committee in 2014–2015. He is currently the 2016–2017 chair of the APhA-APRS ESAS Research Roundtable Committee. In addition to serving as a peer-reviewer, Harpe has served on the editorial advisory boards of several pharmacy-related journals, including the Journal of the American Pharmacists Association (JAPhA). Since 2014, he has served an Associate Editor for JAPhA.


APhA is at the forefront of efforts to gain provider status for pharmacists and advance the pharmacy profession. Thinking specifically about ESAS, I see three priorities in leveraging our skills and experience to support APhA’s stra-tegic efforts: collaboration, preparation, and professional advancement. Col-laboration is crucial when working with diverse groups to achieve a common goal. Beyond APhA’s diverse membership, ESAS itself has notable diversity in terms of professional training, experience, and research interests. By working together, we can bring our unique mix of skills in such areas as research, mar-keting, and education to benefit other areas of APhA. For preparation, we need to consider our own professional development in order to achieve our goals as a section and support APhA’s mission. This will require reflecting on how the needs of ESAS members can be better met through communication or Annual Meeting programming, as well as how we can support each other through mentoring and sharing of ideas. We can also help prepare others through education and mentoring. The first two priorities contribute to the third prior-ity of professional advancement. We must keep in mind how we can support the advancement of pharmacy as a profession when speaking with students, mentoring graduate students or residents, and conducting our own research. Regarding my personal experience and expertise, I have a history of collabo-rating with others in research, practice, and education to meet common goals. As an educator, I have helped prepare students to keep their sights on advanc-ing patient care and improving practice. As an editor, I am dedicated to help-ing others tell their own stories in effective ways. I am excited to be considered for this position and look forward to bringing a spirit of collaboration, a focus on improvement, and a dedication to others should I be elected.

APhA-APRS Economic, Social, and Administrative (ESAS) Section

Chair-elect (2018–2019)

2017 VOTE

AC

AD

EM

Y O

F P

HA

RM

AC

EU

TIC

AL

RE

SE

AR

CH

AN

D S

CIE

NC

E

16

APhA-APRS Economic, Social, and Administrative (ESAS) Section

Chair-elect (2018–2019)

Abby A. Kahaleh, BSPharm, MS, PhD, MPH, has devoted over 20 years of her academic career to pharmacy and health care education. She earned a Doctor of Philosophy (Pharmacy) from the Department of Social and Administrative Sciences at the College of Pharmacy at the University of Michigan, Ann Arbor. She also obtained a Masters in Health Management and Policy from the School of Public Health at the University of Michigan, Ann Arbor. She obtained a Masters of Pharmaceutical

Sciences from the Division of Pharmacy and Healthcare Administration at the University of Toledo after completing her Bachelor of Science in Pharmacy at the University of Damascus.

Recently, Dr. Kahaleh completed several certification programs at the American Pharmacists Association. Specifically, she completed the OTC Advisor Advancing Patient Self-Care, the Pharmaceutical Care for Patients with Diabetes, the Lipid Management Program, the Pharmacists-Provided Immunization Program, and the Delivering Medication Therapy Management (MTM) in the Community. As a Coalition Chair, Dr. Kahaleh collaborated with her colleagues on receiving external funding for develop-ing and implementing a state-wide MTM program.

Dr. Kahaleh published several books, book chapters, and peer-reviewed journal articles. Recently, Dr. Kahaleh collaborated with her colleague on co-editing and publishing an APhA text book entitled “Pharmacy: An Introduction to the Profession.” She also collaborated with her colleagues and pharmacy students on presenting more than 100 research projects and Continuing APhA, the American Association of Colleges of Pharmacy (AACP), and the American Society of Health-System Pharmacists (ASHP). Dr. Kahaleh served on the Advisory Board for the Journal of American Pharmacists Association (JAPhA).

At AACP, she was selected by her peers to serve as the presidential officer of the Curriculum SIG, Experiential Education Section, and Public Health Development Committee. In addition, Dr. Kahaleh was invited by ACPE to participate in several national and global site accreditation visits to pharmacy programs.


My top priorities for the academy are:

First, expanding pharmacists’ role in interprofessional health care teams; Second, elevating pharmacists’ scope of practice in public health; Third, improving professional development among pharmacists and student pharmacists.

Based on the IOM reports, there is a critical need to reform the delivery of health care services in United States. Health care professionals need to pro-vide interprofessional, patient-centered, and team-based health care services. Based on my publication entitled “An Interprofessional Education Panel on Development, Implementation, and Assessment Strategies,” educators and practitioners will benefit greatly from having tools that pharmacists need to implement at their educational institutions and practice sites. I provided pro-fessional development programs at several professional meetings. I believe I have a great opportunity to collaborate with my colleagues at the academy to provide interprofessional education and training programs for pharmacists, practitioners, and future pharmacists.

Second, based on an APhA book entitled “The Pharmacist in Public Health” that I published, pharmacists have distinctive contributions to improve public health. For instance, pharmacists have a critical role to play in meeting the “Healthy People 2020” objectives on the micro- and macro levels. On the micro-level, pharmacists are poised to educate their patients on behavioral and lifestyle modifications to improve outcomes. On the macro-level, pharma-cists are able to advocate for expanding the role of pharmacists in immuniza-tions to close the gap in meeting these objectives. I look forward to continue to collaborate with my public health colleagues on several public health initiatives.

Third, as stated in my recent APhA book entitled “Pharmacy: An Introduction to the Profession,” continuously improving professional develop-ment among pharmacists is critical to moving our profession forward. Having served as a presidential officer at professional associations empowered me to share my knowledge, expertise, and experiences with a large network of students, pharmacists, and practitioners.

2017 VOTE

AC

AD

EM

Y O

F P

HA

RA

MC

Y P

RA

CT

ICE

AN

D M

AN

AG

EM

EN

T

17


Academy of Pharmacy Practice and Management (APhA-APPM) Elections

Spring 2017

Candidates for APhA–APPM offices were asked to respond to the following question. The candidates’ responses are italicized.

(See pages 18–21.)

What are the top three priorities of the Academy and what experiences and expertise can you contribute to meeting these priorities?

APhA-APPM Mission StatementThe APhA Academy of Pharmacy Practice and Management

is dedicated to assisting members in enhancing the profession of pharmacy, improving medication use, and advancing patient care.

Who is Entitled to Vote?All members of the American Pharmacists Association who have designated a Primary Academy and Section (if applicable) are entitled to vote for the leadership of that Academy and Section.

Members who have not designated a Primary Academy and/or Section (if applicable) are encouraged to follow the steps below to fully participate in the 2017 APhA Election:

1. Log-in to your member profile at www.pharmacist.com.2. Select “My Account” in the top right corner.3. Select “Academy, Sections, and SIGs” in the menu bar on the left side.4. Click on “Edit” in the top right corner to be able to choose your Primary Academy and/or Section

(if applicable).5. Designate your Primary Academy and Section (if applicable).6. Designate your Secondary Academy, Section, and/or Special Interest Group preferences (if desired). 7. When your selection(s) are complete, click on the purple “Save” button in the top right corner or the

bottom left corner.

AC

AD

EM

Y O

F P

HA

RM

AC

Y P

RA

CT

ICE

AN

D M

AN

AG

EM

EN

T

18

Catherine Kuhn, PharmD, FAPhA, is a managed care clinical pharmacist at Partners for Kids (PFK), a pediatric accountable care organization affiliated with Nationwide Children’s Hospital in Columbus, Ohio. In her position, she is responsible for improv-ing quality and outcomes of medication-related care as well as managing pharmacy expenditures. She earned her PharmD from Ohio Northern University and completed a community practice residency at The Ohio State University College of Pharmacy and

Kroger Pharmacy. Prior to her current role at PFK, she spent time in academia as a community pharmacy shared faculty member and at two community pharmacy chains as a clinical coordinator. Kuhn is an active member of the American Pharmacists Association (APhA) and the Ohio Pharmacists Association (OPA). She is OPA President-elect (2016–2017) and Vice Chair of OPA’s MTM committee. She has served in leadership positions for APhA including APhA-APPM Executive Member-At-Large, New Practitioner Officer for APhA-APPM’s Community & Ambulatory section, Chair of APhA-APPM Education Committee, and Chair of House of Delegates Policy Review Committee. She was the 2011 recipient of APhA’s Distinguished New Practitioner Award and the 2013 recipient of OPA’s Young Pharmacist Award.


Advancing our profession through innovation and advocacy are aspects that have continually been parts of my professional journey. My work experi-ences have allowed me to be a change agent as I developed a pharmacy chain’s MTM program, served as one of the few community pharmacy faculty members at a college of pharmacy affiliated with an academic medical center, and currently as a managed care clinical pharmacist at a pediatric accountable care organization. As APhA-APPM President, I will bring innovation and advo-cacy to lead our Academy on the top three priorities:

1. Improve communication between pharmacists and other healthcare pro-viders by developing a referral process for pharmacist services and continu-ing work on Health Information Exchange access for pharmacists

2. Promote The Pharmacists’ Patient Care Process, developed by the Joint Commission of Pharmacy Practitioners, to demonstrate the services deliv-ered and improved patient outcomes achieved by pharmacists

3. Integrate pharmacists and pharmacist services into existing and emerging healthcare delivery and payment models, such as value-based care and bundled payments.

My commitment to our profession through my active involvement and leadership in the American Pharmacists Association and the Ohio Pharmacists Association have provided me an opportunity to network with pharmacists and other healthcare providers, where I listen and learn from their valuable experiences and unique perspectives. As a leader for APhA-APPM, I hope to identify and maximize individuals’ strengths, including my own, so we can grow together as one profession to ultimately improve the outcomes of our patients.

Michael Schuh, BS, PharmD, MBA, has more than 30 years of experience managing pharmacies, phar-macist clinical practices and small businesses. Dr. Schuh holds a Florida Pharmacist Consultant License and a Florida Pharmacist license. He is the former Outpatient Pharmacy Operations Manager of Mayo Clinic Jacksonville and has managed various other chain and independent pharmacies in the state of Florida in his career. Dr. Schuh is a clinical, ambu-latory pharmacist and an Assistant Professor of

Pharmacy, Family and Palliative Medicine at Mayo Clinic Florida. Currently, he serves as a primary clinical provider and coordinator of Mayo Clinic Florida’s MTM pharmacy practice serving lung, kidney and liver transplant, bariatric and pharmacotherapy patients. Dr. Schuh is currently a Mayo Clinic Bronze Level Quality Fellow. He is an active member of the Northeast Florida Society of Health System Pharmacists, Florida Society of Heath System Pharmacists, American Pharmacists Association, and Florida Pharmacy Association. On a national level he is past Chair of APhA’s Academy of Pharmacy Practice and Management Administrative Section, Executive Committee, and an APhA Congressional Key Contact. He has served as an active member of APhA’s MTM Task Force and is co-founder and past Coordinator of the APhA Medication Management Special Interest Group and served as Chair of both the Education and Business/Practice Model Committees. Dr. Schuh is also a Clinical Assistant Professor of Pharmacy Practice at the University of Florida, Coordinator of the UF MTM Master of Science program and holds clinical appointments at other leading universities. Outside of pharmacy, he served as a National Quality Forum Advisory Panel Member, Chamberlain College of Nursing Advisory Committee member, and is a Visiting Professor of Nutrition Health and Wellness, Integrated Science, Business Management and Nursing Pharmacology at DeVry University.


As an action oriented, results driven individual, my vision of pharmacy is easy access to pharmacist clinical services for every patient who needs them. Provider status will accelerate access to our services at a much faster rate through better financial support. Being “official” providers will enhance the profession by elevating it to the level of our physician and other allied health professional colleagues. Increased access to our services will automatically improve medication use and advance patient care as already evidenced in the medical literature. My professional experience is broad and deep. The first half of my career, raising my family, was extensive and diverse com-munity experience as staff and management. The second half of my career has been spent mostly as a clinical ambulatory pharmacist and educator, having multiple and varied academic appointments at three major academic institutions and a clinical preceptor for many more. I am an active member in five pharmacy organizations, and most active in APhA as a current APPM Executive Committee officer, Medication Management SIG co-founder, past Medication Management SIG Coordinator and past Chair of APPM’s Practice and Management Administrative Section under APhA’s old officer structure. Other professional activities for APhA and other organizations are many, sustained and diverse. What we have done personally in the past is the foun-dation for what future objectives are. Other than taking care of patients, my primary professional objective is laser focused on making provider status hap-pen as quickly as possible. Then follow with subsequent expansion of phar-macist clinical services into every practical medical venue, making our services available to all. I am an innovative and forward thinking leader. Those familiar with my current and past body of work know the above to be so. I would be humbled and honored to continue serving as an officer of APhA.

APhA-APPM Executive CommitteeAPhA-APPM President-elect (2018–2019)

18

AC

AD

EM

Y O

F P

HA

RA

MC

Y P

RA

CT

ICE

AN

D M

AN

AG

EM

EN

T

19

Brent Thompson, PharmD, is Pharmacy Director at FirstLight Health System in Mora, Minnesota, starting in 2000 as the only Clinical Pharmacist. In his time with FirstLight the practice has grown to 9 pharma-cists and 9 certified technicians practicing in acute, ambulatory, and community; caring for patients in a small rural hospital, 3 rural clinics and a community pharmacy. Brent earned his Pharm.D. at North Dakota State University and has been active in professional associations since his early college years. He finished

a term as President of the Minnesota Pharmacists Association (MPhA) in 2011. In addition to serving and chairing many committees and the board of Directors for MPhA since 2001, he served on the 2012–2013 APhA Policy and Reference Committees and six years in the APhA House of Delegates. His most notable honors include having his FirstLight pharmacy team receive the National Alliance of State Pharmacy Association (NASPA) Excellence in Innovation Award in 2013 and was the recipient of the 2014 APhA Foundation Bowl of Hygeia Award. In addition to his professional work, he is passionate about our future. He introduces high school students to pharmacy through a Careers

Exploration class, maintains a full schedule of interns, and co-coordinates a pharmacy residency. As a community leader, Brent is a director on the Pine County Agricultural Society, bringing thousands of kids to the Pine County Fair each year. In 2015, he was chair for the Substance Abuse Coalition of Kanabec County, working toward the reduction of alcohol, tobacco and other drug abuse among youth and young adults. His passion, second only to phar-macy, is deer hunting in which he serves as Habitat

Director for the Jim Jordan Chapter of the Minnesota Deer Hunters Association. This organization works to educate area youth through hunter education camps in Minnesota.


1. American Opioid Crisis. I began studying, volunteering, advocating, and subsequently presenting about the crisis four years ago. I’ll work with APhA-APPM to empower pharmacists in educating medicine and other health professionals about opioids and the crisis. Additionally, I believe APPM could be the conduit within profession to change the conversations we are having with patients, providing a more blunt understanding of what we are dispensing to them and the risks. Such as “this is Simply a prescription equivalent of Heroin”. As community leaders, pharmacists must get out and speak about the crisis and collaborate with the other groups working on it within their communities. I would like to work with APhA-APPM to develop strong policies around what pharmacists should be doing nationally, as well as at home.

2. Pharmacists Care. We’ve had a busy ambulatory pharmacy practice for nearly 5 years and each year I’m forced to justify its cost through other sources. While most in the profession, medicine, patients, and now even payers agree the value in comprehensive medication management ser-vices has an abundance of evidence, most models still do not allow for a viable practice. I would work with APhA-APPM to continue participation in the development of systems which CMS, payers, and employers will understand, such as SNOMED CT Codes.

3. Care Transitions. My experience as a clinical pharmacist in an acute care setting has opened my eyes to scary situations we often lead our patients into at the community pharmacies. Yet we leave those pharmacists with the great responsibility of helping patients with medications at home. My first strategy with APhA-APPM, would be advocating for The Joint Commission to develop standards requiring hospitals to provide, all infor-mation necessary to safely care for and dispense a discharged patients medications, to the next pharmacist caring for the patient.

Hoai-An Truong, PharmD, MPH, FNAP has been public health pharmacist, educator and leader for twelve years during which he has provided patient-centered care in an interprofessional clinic to optimize medication use and health outcomes, as well as devel-oped and implemented population-based programs to improve community health. He has served as pre-ceptor for pharmacy, physical therapy, and physi-cian assistant students on medical missions to Haiti. Hoai-An is currently associate professor at University

of Maryland Eastern Shore (UMES) School of Pharmacy and Health Professions. Previously, he was chair of department of pharmacy practice at West Coast University, assistant dean for professional affairs at UMES, and assistant then acting executive director of experiential learning program at University of Maryland Baltimore. Hoai-An was also clinical coordinator/pharmacist at Happy Harry’s, a Walgreens Pharmacy. He also provided medication therapy management (MTM) for underserved populations in Primary Care Coalition of Montgomery County clinics. The team received a Lifesaving Patient Safety Award and was featured in the Pharmacy Today magazine. He has also been trainer for APhA’s MTM certificate training program for about 600 pharmacists.

Hoai-An developed, implemented, evaluated and published on MTM process and outcomes. Two of his studies received Merit Presentation Awards at the APhA Annual Meeting and was published in JAPhA. He published over twenty peer reviewed articles and book chapters and presented at national and international conferences. He is co-editor and co-author of a book, The Pharmacist in Public Health: Education, Application, and Opportunities, pub-lished by the APhA. He is past chair of the Public Health Special Interest Group of the American Association of Colleges of Pharmacy and past president of the Maryland Public Health Association (MdPHA) and the Maryland Pharmacists Association (MPhA). He received the Excellence in Innovation Award from the MPhA and is also a Fellow of the National Academies of Practice.


It is my honor to be slated as an APhA-APPM Executive Committee Member-at-Large candidate. As a practitioner-educator in community and ambulatory care pharmacy settings, I have had experiences and devel-oped expertise in providing MTM services to optimize medication use and advance patient care. Having served as president and trustee of the Maryland Pharmacists Association, I have gained experiences in and facilitated opportu-nities for leadership to advance our profession. I also served as co-chair of the APhA Medication Management SIG Education Committee. I believe that these collective patient care and professional services have prepared me to further my engagement at the national level, especially contributing to three APhA-APPM goals, including (1) growth of the Special Interest Groups, (2) leader-ship development, and (3) development of innovative materials to assist pharmacists in offering best practice services, promotion of and participation in MTM services, coordinated care models and provider status.

If elected to be an APhA-APPM Executive Committee Member-at-Large, I will apply my experiences as an APhA MTM certificate program trainer to further pharmacists’ experiences through clinical/educational/leadership pro-gramming and collaborative network through discussion forums and webi-nars to achieve the Academy’s goals. Additionally, I will facilitate the sharing of pearls and advocating for medication management beyond pharmacy at interprofessional meetings. Finally, I will lead the creation of a public health SIG and help facilitate greater recognition of pharmacist’s role and provider status among public health professionals. This can be achieved through tell-ing many more MTM stories with video-clips for legislators and the public as we continue to push for provider status. Thank you for your vote as I want to represent you and support APhA’s mission.

APhA-APPM Executive CommitteeMember-at-large (2018–2020), Pair I

19

AC

AD

EM

Y O

F P

HA

RM

AC

Y P

RA

CT

ICE

AN

D M

AN

AG

EM

EN

T

20

Andrea Brookhart, PharmD, says her passion for pharmacy began when pursuing entry into phar-macy school at the University of Toledo (UT) as an undergraduate. At UT, Andrea became involved in APhA-ASP as a pre-pharmacy student, and turned her attention to community pharmacy and the impact pharmacists have on their patients. Her desire to pursue a community pharmacy residency evolved from her experience as a researcher in the Pharmaceutical Care and Outcomes Research

Laboratory at UT, evaluating the impact Medication Therapy Management (MTM) can have on economic, clinical and humanistic outcomes. Andrea graduated with her Doctor of Pharmacy degree in 2012, and moved to Virginia to continue her education as a community pharmacy resident at Virginia Commonwealth University (VCU) and Kroger Pharmacy. After com-pletion of her residency, Andrea stayed with Kroger Pharmacy as a pharmacist and Patient Care Coordinator (PCC), transitioning to full time PCC in 2014. Since then, Andrea’s focus has been on the coordination of, pharmacist train-ing for, and implementation of clinical services in 16 pharmacies in central Virginia. She performs goal setting and support of MTM and immunization efforts, deliver performance updates, and serves as a clinical subject matter expert to those pharmacies. Within The Kroger Company, Andrea acts as the enterprise Chair for the Medication Therapy Management Workgroup and is a member of Women’s EDGE, a group dedicated to supporting and advancing women personally and professionally. She also serves as the site coordinator and primary preceptor for a community pharmacy resident affiliated with VCU, as well as a preceptor to student pharmacists. Andrea has remained involved in APhA since her time as a student pharmacist, participat-ing as a chapter leader, transitioning to involvement as a new practitioner on the Transitions Editorial and Advisory Board, and now as an active member of the APhA Academy of Pharmacy Practice and Management.


I believe that APhA-APPM’s first priority is Provider Status for pharmacists. Rallying pharmacists, patients, and other healthcare providers to help achieve Provider Status is paramount. Improving access to patient care for the medi-cally underserved communities will lead to positive outcomes for patients’ health, healthcare spending, and for pharmacists providing these services. I have experienced how rewarding it can be to provide direct patient care, through MTM and health coaching in the community as well as collaborative drug therapy management in a clinic setting. I hope to promote the advocacy each of our members and potential members can perform as APhA-APPM Member-at-Large.

The second priority of the Academy should be to improve the provi-sion of patient care through improving collaboration between pharmacists. Engagement of practicing pharmacists in the Academy’s special interest groups (SIGs) provides a mechanism for collaboration across the country. Pharmacists can share clinical pearls, best practices for implementation of new services, and ideas for collaboration with other healthcare providers. Additionally, the creation of education and resources through SIGs helps improve the patient care provided on the ground, every day, by its members.

The third priority of the Academy should be to advance patient care through collaboration with other healthcare providers. As a member of the Medication Management SIG’s Business Model Workgroup, I have begun to participate in the creation of a toolkit for marketing MTM to other health-care providers, and I realize the importance of this type of collaboration. Pharmacists collaborating on interdisciplinary healthcare teams are able to

improve health outcomes for patients through diabetes management, provid-ing immunizations, providing pain management services, improving transi-tions of care, and so much more.

Ultimately, each of these priorities fits into the mission of APhA-APPM: to assist its members in enhancing the profession of pharmacy, improving medi-cation use, and advancing patient care.

Monali Majmudar, PharmD, earned her Doctor of Pharmacy degree from the Mercer University College of Pharmacy in 1998. She practices as a pharmacy manager for a 24-hour community phar-macy in Norcross, Georgia. Beyond her normal daily pharmacy duties, Dr. Majmudar is in charge of coor-dinating and updating immunization training for over 100 pharmacy locations in the Atlanta market. She is also certified to teach APhA Pharmacy Based Immunization Delivery and Travel Health Services

Programs. Concurrently, she further continues to promote the importance of immunizations and often partners with government agencies/consulates and the Mercer University Physician Assistant Program. She holds a Clinical Assistant Professor of Pharmacy Practice appointment with Philadelphia College of Osteopathic Medicine (PCOM) School of Pharmacy. At her clinical site, she progresses the pharmacy profession forward by mentoring IPPE and APPE students from both Mercer University and the PCOM School of Pharmacy. In addition, Dr. Majmudar is the recipient of many pharmacy industry awards, including the 2014 APhA Immunization Champion Award for Community Outreach, the 2013 Mercer University College of Pharmacy IPPE Preceptor of the Year Award, the 2013 APhA-ASP Friend of Pharmacy Award with Mercer University, the 2013 Health Stat Outstanding Provider Award, the 2012 APhA National One to One Patient Counseling Recognition Award, and the 2010–2011 APhA National Immunization Award.


As APhA-APPM Executive Committee Member-at-Large, I believe the top 3 priorities of the Academy are

1. To promote pharmacist provider status2. To increase the public awareness of pharmacist roles as the medication

therapy specialist, not just the dispenser3. To encourage pharmacists to actively pursue being a participating mem-

ber of an interdisciplinary healthcare team focused on improving patient outcomes.

My position as a community pharmacist and immunization trainer has allowed me to network and demonstrate the value of the pharmacist as a healthcare provider and an indispensable member of the healthcare team. I can share and teach practical tips, which can help solidify our role and position as healthcare providers and also to provide growth in interdisciplinary clinics for the underserved and the general population. Having already established valuable connections with organizations such as the Community Health and Social Services, the Human and Health Services, Georgia Head Start, and the Hispanic Health Coalition of GA, I will continue to reinforce the value of pharmacists to the community and healthcare team. My media experience with local radio and news stations will help continue to increase public aware-ness about the valuable services that pharmacists provide. As APhA-APPM Executive Committee Member-at-large, I will use these connections, as well as my leadership, interpersonal, and self-motivational skills, to encourage and motivate pharmacists and further our profession.

Member-at-large (2018–2020), Pair II

APhA-APPM Executive Committee

AC

AD

EM

Y O

F P

HA

RA

MC

Y P

RA

CT

ICE

AN

D M

AN

AG

EM

EN

T

21

Denise Clayton, BSPharm, is a clinical pharma-cist for AR Blue Cross Blue Shield for Commercial Pharmacy operations. Over the past two years, Denise has served as the Coordinator-elect and Coordinator for the Medication Management Special Interest Group. She has coordinated the work of 4 commit-tees of the MM SIG focusing on projects to provide tools and resources for all APhA members interested in providing MTM and patient care services.

Denise’s previous experiences have included working as the Manager of Clinical Initiatives and MTM for a pharmacy risk management company, providing MTM services for patients in community pharmacies, serving as a Clinical Consultant Pharmacist and practicing as a hospital pharmacist at a large hospital in Little Rock, AR.

Denise has completed the APhA certificate training programs, Delivering Medication Therapy Management Services, Pharmacist and Patient-Centered Diabetes Care and Pharmacy Based Immunization Delivery. As a faculty trainer, Denise teaches the Delivering Medication Therapy Management Services program to other pharmacists in Arkansas.

She is a member of the Arkansas Pharmacists Association where she is the District 1 President and is a preceptor for UAMS College of Pharmacy.


As the APhA-APPM Executive Committee Member-at-Large, I will gladly serve our profession by focusing on what I believe are our top three priorities:

1. To continue to lead the efforts of pharmacists to be recognized with provider status.

2. To develop resources, programs and tools for our members to utilize in order to provide quality patient care and improve outcomes while lower-ing the cost of healthcare.

3. To encourage pharmacists across the country to get involved or continue to be actively involved in our profession. Healthcare is changing and we need to be at the table!

It astounds me that our country spends over $300 billion a year in avoid-able healthcare cost due to medication related problems. Pharmacists are well equipped with the knowledge and skills to help address these medica-tion related problems, resulting in improved outcomes of our patients and a decrease in the huge cost burden to our healthcare system.

Over the past 2 years, as the Coordinator-elect and Coordinator of the Medication Management SIG, I led our SIG in surveying our members about their needs in providing MTM services for their patients and in developing tools and resources to meet their needs so that they can arm their patients with the knowledge they need to do better in taking care of their health! I have also taught the APhA Delivering Medication Therapy Management Services certificate training program and other MTM related continuing edu-cation courses.

Through these experiences I have learned from my colleagues what their needs and ideas are in providing improved patient care and have worked to help meet those needs. As a member of the APPM Executive Committee, I will continue to serve APhA members and the pharmacy profession to develop processes and programs to provide better patient outcomes. Knowledge is Power!

Sheila Seed, PharmD, MPH, RPh, is a Professor of Pharmacy Practice at MCPHS University, School of Pharmacy Worcester/Manchester. She has been with the University since 2001 and teaches in sev-eral courses related to public/global health, has an ambulatory care practice site and works col-laboratively with an infectious disease specialist at a travel clinic. She received her B.S. Pharmacy from the Massachusetts College of Pharmacy and Health Sciences, a Master’s in Public Health from

the University of Massachusetts, Amherst and a Doctor of Pharmacy from Idaho State University. She also served as a pharmacy officer in the in the U.S. Air Force. She is a member of a several professional societies, including the International Society of Travel Medicine, where she serves as a phar-macy steering committee member; the American Association of Colleges of Pharmacy where she has served on a number of committees within the Public Heath SIG, and the American Pharmacists Association, where she serves as the Immunizing Pharmacists SIG Coordinator.


1. Align APhA-APPM Academy Leadership priority goals, objectives, and tactics and action steps to the strategic plan priorities of the Association.

As a member of our School of Pharmacy Strategic Plan Committee and as a past Vice-Chair of my department I was responsible was developing strate-gic plan goals and assessing our achievements.

2. Convene and engage members in structured workgroups to complete projects with defined scope of work that produces specific deliverables and work products.

As the Coordinator of the Immunizing SIG, I worked closely with the chairs of each committee to develop a user friendly guide for pharmacists in regards to immunizations. I have a solid background in leading people to complete projects/goals. My experience in the military and in positions of leadership in my work experience (Associate chief and Chief of Pharmacy services and Vice-Chair of the department of pharmacy practice), has given me the skills to work well with people. It is vital that this organization pro-vide pharmacists with best practices.

3. Actively engage members to provide feedback, input and guidance to staff in the completion of work products of the Association.

As Coordinator of the Immunizing Pharmacists SIG I was able to work closely with APhA staff and committee members to complete various projects. Communication is a key component for success. I have a proven record of completing projects with the input from all members of various committees within the SIG.

Member-at-large (2017–2019), Pair III

APhA-APPM Executive Committee

American Pharmacists Association

2215 Constitution Avenue, NW

Washington, DC 20037-2985

22

2017 - American Pharmacists Association Voters Guide 2017.pdf2017 VOTER’S GUIDE ... Rebecca W....

Documents

Transcript of 2017 - American Pharmacists Association Voters Guide 2017.pdf2017 VOTER’S GUIDE ... Rebecca W....